Free Trial

EU-Drugmaker Talks On COVID-19 Vaccine Hit Snag - Reuters

EUROPEAN PRESS

Reuters are reporting that talks between the European Union and 3
drugmakers (Pfizer, Sanofi, J&J) regarding the purchase of potential
COVID-19 vaccines have hit snags.

  • Price, payment methods, and liability costs are all listed as sticking
    points for the drugmakers according to EU officials.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.